Phoenixville, PA, United States of America

David John Payne

USPTO Granted Patents = 21 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 87(Granted Patents)


Location History:

  • Phoenixville, PA (US) (1998 - 2006)
  • Collegeville, PA (US) (2000 - 2006)

Company Filing History:


Years Active: 1998-2006

Loading Chart...
21 patents (USPTO):Explore Patents

Title: The Innovations of David John Payne: A Pioneer in Antibacterial Technologies

Introduction: David John Payne, based in Phoenixville, PA, is a notable inventor recognized for his significant contributions to the field of biotechnology. With a remarkable portfolio of 21 patents, he has dedicated his career to developing innovative solutions aimed at combating bacterial infections.

Latest Patents: Among his latest innovations are two important patents that focus on the FabK polypeptides. The first patent, "FabK variant," outlines the invention of FabK polypeptides and the polynucleotides encoding these polypeptides, along with methods for their production through recombinant techniques. This breakthrough provides an effective approach for screening antibacterial compounds. The second patent, "Methods of agonizing and antagonizing FabK," presents methods utilizing agonists and antagonists of FabK polypeptides, particularly aimed at modulating bacterial metabolism or treating bacterial infections.

Career Highlights: David has made significant strides in the pharmaceutical industry, having worked with renowned companies such as SmithKline Beecham Corporation and Affinium Pharmaceuticals, Inc. His experience in these firms has been instrumental in translating his innovative ideas into practical applications that enhance antibiotic therapies.

Collaborations: Throughout his career, David has collaborated with esteemed colleagues, including Stewart Campbell Pearson and John Timothy Lonsdale. These partnerships have fostered a productive environment for innovation and research, leading to many of the advancements seen in his patents.

Conclusion: David John Payne's work exemplifies the spirit of innovation within the biotechnology sector, particularly in the development of novel antibacterial strategies. His patents stand as a testament to his expertise and dedication to improving health outcomes through scientific advancement. As the battle against bacterial infections continues, inventors like David play a crucial role in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…